Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a global leader in regenerative agriculture solutions, announced its financial results for the fiscal third quarter ended March 31, 2025. The company reported total revenues of $60.6 million and an adjusted EBITDA of $9.0 million, while net loss for the quarter stood at $1.6 million.

Significant improvement in cash flow marked the quarter, with net cash flow from operating activities reaching $23.3 million, representing a $40.7 million increase year-over-year. This was largely driven by efficient inventory and receivables management, as well as organizational restructuring within the seed business.

Revenue Breakdown:
– Crop Protection: $38.0 million (down 19%)
– Seed and Integrated Products: $10.9 million (up 26%)
– Crop Nutrition: $11.8 million (down 59%)

Key Highlights:
– EPA registration obtained for Rinotec™, a next-generation biological insecticide and nematicide.
– Strategic shift in the seed business enabled the exchange of non-core traits and reduced third-party royalty obligations.
– Operating profit stood at $0.9 million despite a seasonally low quarter and tough market conditions in Argentina.

Management Commentary:

Federico Trucco, CEO: “Our standout achievement this quarter was not just financial, but operational. The $40 million YoY improvement in cash flow is a testament to disciplined execution. Rinotec’s approval allows us to expand our biological footprint with solutions that are agronomically sound and commercially scalable.”

Milen Marinov, Chief Commercial Officer: “Rinotec is a transformative technology with applications in both row and specialty crops. With approvals in the US and Brazil, we’re ready to meet the growing demand for bio-based alternatives in global agriculture.”

Enrique Lopez Lecube, CFO: “We made notable progress in streamlining our cost structure and optimizing working capital. These steps were essential as we look to scale up and introduce new solutions in upcoming quarters.”

Conclusion:
While total revenues declined due to the absence of last year’s Syngenta downpayment, Bioceres maintained positive momentum by strengthening operational discipline and preparing for long-term growth through innovation. The Rinotec™ platform positions the company at the forefront of sustainable pest control and integrated biological solutions worldwide.

Source – Bioceres